DNA Methylation-Based Biomarkers of Protein Levels and Cardiovascular Disease Risk: Opportunities and Challenges for Precision Cardiology

Circ Genom Precis Med. 2024 Apr;17(2):e004571. doi: 10.1161/CIRCGEN.124.004571. Epub 2024 Feb 13.

Authors

Anne K Bozack¹, Ana Navas-Acien², Andres Cardenas^{1

3}

Affiliations

¹ Department of Epidemiology and Population Health (A.K.B., A.C.), Stanford University School of Medicine, CA.
² Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY (A.N.-A.).
³ Department of Pediatrics (A.C.), Stanford University School of Medicine, CA.

PMID: 38348680
PMCID: PMC11021153 (available on 2025-04-01)
DOI: 10.1161/CIRCGEN.124.004571

No abstract available

Keywords: DNA methylation; Editorials; aging; biomarkers; cardiovascular diseases; cohort studies; gene expression profiling.

Publication types

Editorial
Comment

MeSH terms

Cardiology*
Cardiovascular Diseases* / genetics
DNA Methylation
Epigenesis, Genetic
Genetic Markers
Humans

Substances

Genetic Markers

Grants and funding